Reverse genetics open new path to norovirus vaccine and drug development

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...
AlphaGalileo

New method to accelerate vaccine and drug development for norovirus

Researchers from The University of Osaka have developed a novel reverse genetics system to study norovirus, the leading cause ...
JD Supra

Sarepta Files Two IPRs Against Genzyme’s Patents Related to Gene Therapy Elevidys®

On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to ...

Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

Woolworths-backed biotech All G raises $10m to create ‘bio-identical’ human breast milk

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...
The Manila Times

Kraig Biocraft Laboratories Secures Usage Rights to Strategic Government-Owned Mulberry Gardens to Support Major Spider Silk Production Expansion

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('Company' or 'Kraig Labs'), a world leader in spider silk technology*, today announced that it has been granted usage rights to a significant block of ...
The Malaysian Reserve

GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...